Table 1. Baseline characteristics of study participants.
| Total | Men | Women | |
|---|---|---|---|
| n | 1,123 | 539 | 584 |
| Age (years) | 48.6 ± 16.4 | 48.9 ± 16.4 | 48.2 ± 16.4 |
| BMI (kg/m2) | 28.3 ± 5.6 | 28.5 ± 4.9 | 28.0 ± 6.2 |
| Waist (cm) | 96.4 ± 16.9 | 100.6 ± 15.0 | 92.4 ± 17.7 |
| Triglycerides (mg/dl) | 139 ± 116 | 153 ± 142 | 125 ± 82 |
| Total cholesterol (mg/dl) | 191 ± 39 | 190 ± 38 | 191 ±40 |
| HDL cholesterol (mg/dl) | 47.1 ± 13 | 41.5 ± 9.8 | 52.2 ± 13.7 |
| LDL cholesterol (mg/dl) | 121 ± 31 | 123 ± 30 | 120 ± 32 |
| Fasting glucose (mg/dl) | 101 ± 19 | 106 ± 21 | 98 ± 16 |
| Fasting insulin (μU/ml) | 13.7 ± 8.2 | 14.2 ± 8.4 | 13.3 ± 7.9 |
| Systolic blood pressure (mmHg) | 115 ± 17 | 118 ± 15 | 112 ± 17 |
| Diastolic blood pressure (mmHg) | 68 ± 9 | 71 ± 9 | 66 ± 9 |
| C-reactive protein (mg/l) | 2.48 ± 5.0 | 1.88 ± 3.75 | 3.03 ± 5.78 |
| Interleukin-6 (ng/l) | 1.98 ±3.11 | 2.07 ± 4.15 | 1.89 ± 1.63 |
| Current smoker | 86 (7.7) | 42 (7.8) | 44 (7.6) |
| Current drinker | 562 (50) | 266 (49) | 296 (51) |
| Hormone treatment | 122 (11) | — | 122 (21) |
| Metabolic syndrome | 381 (34) | 205 (38) | 181 (31) |
Data are means ± SD or n (%).